Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $4,046 - $4,526
-48 Reduced 1.76%
2,679 $247,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $15,886 - $20,927
-219 Reduced 7.43%
2,727 $260,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $1,234 - $1,555
-20 Reduced 0.67%
2,946 $224,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $4,156 - $5,602
-60 Reduced 1.98%
2,966 $205,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $4,118 - $5,364
50 Added 1.68%
3,026 $250,000
Q4 2021

Jan 14, 2022

BUY
$106.37 - $130.68 $316,557 - $388,903
2,976 New
2,976 $386,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track White Knight Strategic Wealth Advisors, LLC Portfolio

Follow White Knight Strategic Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of White Knight Strategic Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Knight Strategic Wealth Advisors, LLC with notifications on news.